A Comparative Western Immunoblot Antibody Titration Test for Evaluation of Bartonella Therapy  by Hardy, W.D. & Zuckerman, E.E.
13th International Congress on Infectious Diseases Abstracts, Poster Presentations e465
70.018
Introduction of a New Housekeeping Gene Sequences for
Rapid Identiﬁcation of Vibrio cholerae Strains in the Clin-
ical Samples
A. Dashtebani ∗, B. Bakhshi, M. Oskui, M.R. Pourshaﬁe
Pasteur Institute of Iran, Tehran, Iran (Islamic Republic of)
Background: Vibrio cholerae is a noninvasive, gram-
negative bacterium responsible for severe epidemics of
cholera and endemic diarrhea in many parts of the world,
especially developing countries. Vibrio cholerae strains may
produce a variety of atypical biochemical reactions which
may pose some difﬁculties in rapid identiﬁcation and recov-
ery of these bacteria from mixed samples isolated from
clinical or environmental sources. To best of our knowledge
dnaE gene is widespread among all Vibrio cholerae strains.
Our study is aimed at developing the use of PCR ampliﬁ-
cation of dnaE housekeeping gene as a screening tool for
identiﬁcation of Vibrio cholerae among mixed clinical sam-
ples and comparison with the time consuming conventional
biochemical methods.
Methods: A total of 24 Vibrio cholerae isolates of clinical
origin isolated and subjected to serogrouping and subse-
quent PCR analysis using primers which speciﬁcally chosen
to amplify within the dnaE gene in the genome of the Vibrio
cholerae isolates. Vibrio cholerae ATCC 14035 and Pseu-
domonas aeruginosa ATCC 27853 were used as positive and
negative controls in each assay
Results: Among 24 Vibrio cholerae isolated, 21% identi-
ﬁed as Ogawa and the remaining 79% as Inaba serogroup.
PCR analysis of the dnaE housekeeping gene revealed the
presence of this gene in 100% of isolates examined and
approximately 300 bp product was obtained from the iso-
lates. The identity of the product was further conﬁrmed
using RFLP assay
Conclusions: The result of this study suggest the use of
dnaE housekeeping gene as a molecular marker for rapid
identiﬁcation of Vibrio cholerae in mixed clinical samples.
doi:10.1016/j.ijid.2008.05.1316
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Bacterial DNA Load in Cerebrospinal Fluid During Treat-
ment of Bacterial Meningitis
N.V.T. Tran1,∗, M.H. Nguyen2, J. Farrar1, C. Schultsz1
1 Oxford University Clinical Research Unit, Ho Chi Minh,
Vietnam
2 Hospital for Tropical Diseases, Ho Chi Minh, Vietnam
Background: Bacterial meningitis is an important cause
of morbidity and mortality in Vietnam. The diagnosis can be
difﬁcult to establish, e.g. due to frequent pretreatment with
antimicrobial agents. We developed a quantitative real-time
PCR (qRT-PCR) to determine the bacterial DNA load in CSF
during treatment of four major pathogens causing bacterial
meningitis in Vietnam.
Methods:CSF samples were collected from 445 patients
with suspected bacterial meningitis on hospital admission,
after 48 hours, and 6—15 days after admission. Primers
and probes for detection of Steptococcus pneumoniae (Sp),
Haemophilus inﬂuenzae b (Hib) and Neisseria meningitidis
(Nm) were as described previously by Corless et al. Primers
and probe for Streptococcus suis type 2 (SS2) detection were
designed using Primer Express. PCR fragments were cloned
in TA cloning vector. Serial 10 fold-dilutions of puriﬁed plas-
mid served as external standards for real-time quantitation
Results:SS2 was detected in 149 (33.5%) of samples col-
lected on admission, Sp in 79 (17.8%), Nm in 29 (6.5%)
and Hib in 5 (1.1%) using RT-PCR. The median bacterial
DNA load on admission was 1.48× 106 DNA copies/ml (range
1.0× 103—1.1× 108) for SS2, 4.98× 105 DNA copies/ml
(range 1.0× 103—9.1× 109) for Sp, 3.37× 106 DNA copies/ml
(range 1.0× 103—1.13× 108) for Nm. Clearance of bacterial
DNA was gradual. Median bacterial DNA loads of SS2, SP and
Nm were similar at each of the sampling times. DNA was
still detectable in 69/156 (44.2%) samples collected 6—10
days after start of treatment and in 17/53 (32.07%) samples
collected after 11—15 days
Conclusions:Median bacterial DNA loads are similar in
meningitis caused by SS2, Sp and Nm but are highly vari-
able when comparing individual patients. DNA loads decline
only gradually during treatment, enabling diagnosis by PCR
even after start of antimicrobial treatment. qRT-PCR can be
used to study the association between bacterial DNA load
and clearance and outcome.
doi:10.1016/j.ijid.2008.05.1317
70.020
A Comparative Western Immunoblot Antibody Titration
Test for Evaluation of Bartonella Therapy
W.D. Hardy Jr. ∗, E.E. Zuckerman
National Veterinary Laboratory, Inc., Franklin Lakes, NJ,
USA
Introduction: Bartonella are zoonotic pathogens mainly
transmitted by cats and occasionally dogs. They are difﬁ-
cult to isolate and most Bartonella infections of animals or
people are diagnosed by detection of coexisting antibody
(IgG).
Methods: We developed a single dilution western
immunoblot (WB) for detection of Bartonella antibodies (IgG
1:100) for determination of Bartonella spp. infection. We
adapted this test in a comparative titration format (pre
and 6 months post therapy) to assess the elimination of
Bartonella from cats, dogs and people
Results: Bartonella was isolated from 7 seropositive pet
cats before doxycycline therapy. All 7 cats were culture neg-
ative 1 month post therapy but at 6 months only 5 of the 7
cats remained culture negative. All 5 of the culture negative
cats had a titer decrease of 4 fold (n = 4) and 2 fold (n = 1)
whereas the 2 cats where Bartonella was isolated 6 months
post therapy had no titer decrease. In contrast, there was no
titer decrease in 21 untreated Bartonella-seropositive pet
cats observed for more than 1 year. 9,782 titrations were
performed on Bartonella-seropositive pet cats 6 months
after treatment with: azithromycin (n = 9,162), rifampin
(n = 469) and doxycycline (n = 151). A 2 fold titer decrease
occurred in 1,119 cats (11.4%) and a 4 fold or greater titer
decrease occurred in 7,583 cats (76.5%). Thus, post ther-
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apy titer decreases (treatment success) occurred in 87.9%
of Bartonella-infected cats. 78 of 88 (88.6%) Bartonella-
seropositive dogs had post therapy titer decreases (2 fold
n = 8, 4 fold or greater n = 70) as did all 3 people with CSD (4
fold or greater).
Conclusion: Antibiotic therapy of Bartonella-seropositive
cats, dogs, and people can be effectively monitored using a
comparative WB titration test.
doi:10.1016/j.ijid.2008.05.1318
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Development of a Slide Latex Agglutination Assay for Iden-
tiﬁcation and Conﬁrmation of Burkholderia pseudomallei
from Cultures
S. Jeyanthi ∗, J. Thimma, J. Vadivelu, C.S. Hung
University Malaya, Kuala Lumpur, Malaysia
Keywords: Latex particles; Monoclonal antibody; Sensitiv-
ity; speciﬁcity
Culture and biochemical assay remain as ‘‘gold stan-
dard’’ for identiﬁcation and conﬁrmation of B. pseudoma-
llei. However conﬁrmation by API 20NE biochemical assay
is time consuming as the identiﬁcation can only be done
24 hours onwards up to a week. Consequently, treatment of
the patients suspected for melioidosis can be delayed and
increases mortality rate as death can occur within 24 hours
onset of the disease. Therefore there is a need to develop an
assay that can shorten the time for identiﬁcation and con-
ﬁrmation of B. pseudomallei from cultures. In this study, a
rapid slide agglutination assay was developed using a speciﬁc
monoclonal antibody raised against culture ﬁltrate antigen
of B. pseudomallei in Balb-C mice. The puriﬁed monoclonal
antibody was tagged onto 0.8 um latex particles by means of
passive adsorption. Latex agglutination assay was performed
on a total of 45 B. pseudomallei strains and additional of ﬁve
other Burkholderia species on glass microscope slide. Cross
reactivity studies were performed on control panel strains
which consisted of various gram-negative and gram-positive
organisms. The latex agglutination assay was able to identify
correctly 44 of 45 B. pseudomallei strains with a remarkable
sensitivity of 97.8% and speciﬁcity of 100%. No cross reac-
tion was observed with the control panel strains. In addition,
latex agglutination assay was also performed on various B.
pseudomallei antigen and compared with the developed
assay. It was found that the developed latex agglutination
assay is useful in identiﬁcation and conﬁrmation of B. pseu-
domallei from cultures.
doi:10.1016/j.ijid.2008.05.1319
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Pneumocystis jiroveci Pneumonia (PCP) Diagnosis by
Direct Fluorescent Antigen Detection
W. Wootta ∗, P. Panyaruggit, P. Sawanpanyalerd
National Institute of Health, Nonthaburi, Thailand
Background: To compare the results of Direct Fluorescent
antigen detection (DFA) with the routine direct examina-
tion as Giemsa stain, Toluidine blue O stain and Ammoniacal
silver stain for detecting Pneumocystis jiroveci pneumonia
(PCP) in bronchoalveolar lavage spacimens (BAL) taken from
symptomatic HIV seropositive patients.
Methods: Bronchoalveolar lavage specimens were exam-
ined from 57 symptomatic HIV seropositive patients sending
to National institute of Health, Thailand. Specimens were
examined for PCP using routine direct examination as
Giemsa stain, Toluidine blue O stain and Ammoniacal silver
stain and by Direct Fluorescent antigen detection (DFA)
Results: Of the 57 specimens analysed were 24 posi-
tive by DFA. An addition two specimens were routine direct
examination negative and DFA positive. Compared to rou-
tine direct examination, the sensitivity and speciﬁcity of the
DFA assay for the detection of P. jiroveci from BAL specimens
sensitivity, speciﬁcity of were 100 and 94.3%. By the way pos-
itive predictive value (PPV), negative predictive value (NPV)
and efﬁciency were 91.7 and 100 and 96.5%, respectively
Conclusions: this study has shown that DFA assay for the
detection of P. jioveci has a high sensitivity and speciﬁcity
and can be adapted for use in the clinical microbiology lab-
oratory reqire ﬂuorescent microscopy.
doi:10.1016/j.ijid.2008.05.1320
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Construction of the Internal Controls Using the Same
Primers of the Target to Verify PCR and QPCR Results for
Diagnosis
P. Hung Van1,∗, V.D. Xuyen An2, H.T. Thuy Loan2, H. Hieu
Ngoc1, L. Thuy Quyen1
1 University of Medicine and Pharmacy, Ho Chi Minh City,
Vietnam
2 Nam Khoa Co. Ltd., Ho Chi Minh City, Vietnam
Background: Current PCR and qPCR methods used in
detecting and/or quantifying pathogenic agents present in
patient sample have become the essential application for
most diagnostic laboratories. Despite these methods have
high sensitivity, technical issues are currently the most inﬂu-
encing factors for the quality of these present in-house
methods. Therefore, development of a good quality control
protocol has now become the vital next step.
Objectives: To develop and to construct the internal
control using the same primers of the target in order to stan-
dardize the quality of PCR and qPCR results used in pathogen
diagnosis.
Methods: Based on the molecular biotechnology, we
designed and developed the internal controls which can be
used with the same primers as for the target. After that,
the LOD (limit of detection) concentration that can give
detectable signal without inhibiting ampliﬁcation of the tar-
get, were determined for these internal controls. These
LOD determinations are very essential since the input of
the internal control at the LOD to the samples and to the
negative control sample can control the sensitivity of the
nucleic extraction, the ampliﬁcation; can detect the con-
tamination as well as the inhibition without the need of
multiple controls as usual
Results: Using the mentioned methods, various designed
internal controls have been designed and constructed for
